These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Arrestin(g) podocyte injury with endothelin antagonism. Tan RJ; Liu Y J Am Soc Nephrol; 2014 Mar; 25(3):423-5. PubMed ID: 24371299 [No Abstract] [Full Text] [Related]
3. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Rosanò L; Cianfrocca R; Masi S; Spinella F; Di Castro V; Biroccio A; Salvati E; Nicotra MR; Natali PG; Bagnato A Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2806-11. PubMed ID: 19202075 [TBL] [Abstract][Full Text] [Related]
4. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497 [TBL] [Abstract][Full Text] [Related]
5. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling. Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212 [No Abstract] [Full Text] [Related]
6. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176 [TBL] [Abstract][Full Text] [Related]
7. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway. Wang Y; Li H; Song SP Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435 [TBL] [Abstract][Full Text] [Related]
8. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737 [TBL] [Abstract][Full Text] [Related]
9. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells. Ebefors K; Wiener RJ; Yu L; Azeloglu EU; Yi Z; Jia F; Zhang W; Baron MH; He JC; Haraldsson B; Daehn I Kidney Int; 2019 Oct; 96(4):957-970. PubMed ID: 31402170 [TBL] [Abstract][Full Text] [Related]
10. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease. Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087 [TBL] [Abstract][Full Text] [Related]
11. beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. Imamura T; Huang J; Dalle S; Ugi S; Usui I; Luttrell LM; Miller WE; Lefkowitz RJ; Olefsky JM J Biol Chem; 2001 Nov; 276(47):43663-7. PubMed ID: 11546805 [TBL] [Abstract][Full Text] [Related]
13. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471 [TBL] [Abstract][Full Text] [Related]
14. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. Teoh JP; Park KM; Wang Y; Hu Q; Kim S; Wu G; Huang S; Maihle N; Kim IM Cell Signal; 2014 Dec; 26(12):2885-95. PubMed ID: 25194819 [TBL] [Abstract][Full Text] [Related]
15. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668 [TBL] [Abstract][Full Text] [Related]
16. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis. Lenoir O; Milon M; Virsolvy A; Hénique C; Schmitt A; Massé JM; Kotelevtsev Y; Yanagisawa M; Webb DJ; Richard S; Tharaux PL J Am Soc Nephrol; 2014 May; 25(5):1050-62. PubMed ID: 24722437 [TBL] [Abstract][Full Text] [Related]
17. β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy. Liu J; Li QX; Wang XJ; Zhang C; Duan YQ; Wang ZY; Zhang Y; Yu X; Li NJ; Sun JP; Yi F Cell Death Dis; 2016 Apr; 7(4):e2183. PubMed ID: 27054338 [TBL] [Abstract][Full Text] [Related]
18. Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering β-catenin transcriptional activity under high glucose conditions. Lv Z; Hu M; Zhen J; Lin J; Wang Q; Wang R Int J Biochem Cell Biol; 2013 Feb; 45(2):255-64. PubMed ID: 23153508 [TBL] [Abstract][Full Text] [Related]
19. Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism. Harvey TW; Engel JE; Chade AR Am J Nephrol; 2016; 43(2):74-84. PubMed ID: 26930122 [TBL] [Abstract][Full Text] [Related]
20. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Buchanan FG; Gorden DL; Matta P; Shi Q; Matrisian LM; DuBois RN Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1492-7. PubMed ID: 16432186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]